About the organization
Basic details : A pioneer in healthcare. We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Mission : Our purpose
Doing now what patients need next
We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
That is why we come to work each day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.
We are Roche.
Vision : Our Business Priorities
We believe in the importance of having a clear set of priorities to guide us through a turbulent and ever-changing environment. Our aim is to achieve long term sustainable growth and deliver value to all our stakeholders.
Focus on patients
We focus on developing innovative medicines and diagnostic tests that help patients live longer, better lives. Two-thirds of all diseases are either still not treated adequately or not treated at all. This medical need is enormous and better diagnostics and medicines can make a huge difference to the lives of millions of patients and their families.
Excellence in science
We strive to address unmet medical needs through excellence in science. Breakthroughs in science and technology increasingly allow us to find out precisely what is malfunctioning in the body and develop drugs to counter the problem. We focus on oncology, immunology, ophthalmology, infectious diseases and neuroscience, however we remain flexible and follow the science as new insights become available.
We combine our strengths in pharmaceuticals and diagnostics to better fit treatments to patients. When genetic differences can be identified, the efficacy and safety of medicines can be improved enormously. To this end we have a companion diagnostic strategy for every molecule we develop.
Access to healthcare
We aim to bring our medicines and diagnostic tests to as many people in need as possible. Every healthcare system comes with different challenges and we customise solutions for individual markets. We work with many different local partners to reduce barriers to accessing healthcare and establish innovative, sustainable ways to bring effective and affordable healthcare to patients
We are committed to constantly strengthening and maintaining an excellent workplace where every person feels valued and respected and can grow to his or her full potential. Our people make our business. They discover, develop and manufacture our products and ensure they reach the patients who need them. We believe that the key to our success lies in our ability to attract, retain and motivate a highly skilled and diverse workforce.
We run our business in a way that is ethical and aims to create long-term value for all stakeholders. We want to create value through developing medical solutions and we aim for as many people to benefit from them as possible. We believe that our success lies in our ability to develop strategies where both industry and society benefit in a sustainable way.
|Address||Grenzacherstrasse 124, 4070 - Basel, CH|
Head of Patient Engagement, PD Medical Affairs
Head Global Medical Liaisons and Communications
Patient & Population Director, Rare Diseases
- Geographic focus
- Time line
- Completed over one year ago
- Added on
I commit to listen to and truly co-create with patients right at the beginning of an initiative/project/idea.Work in progress
I commit to continuously engage in discussions with all stakeholders to help shift the mindset towards true patient-centricity.Work in progress
Patient Engagement Director
I will work to systematically integrate the patient perspective in development of medicines. To do this, I must listen to the patient needs through patient forums, surveys and other channels.Work in progress